Due to the recent passing of Key Opinion Leader Dr. Stephen Harrison, we will be postponing the Sagimet Biosciences Virtual…

Join Benitec Biopharma for a virtual R&D Day, featuring two key opinion leaders who will discuss the clinical symptoms and…

Details to follow.

Join Cognition Therapeutics for a virtual KOL Event, featuring Martin J. Sadowski, MD, PhD, DSci (New York University School of Medicine),…

Please join Praxis Precision Medicines for a virtual update on its PRAX-628 Program. Praxis’ management will lead the discussion and…

Join us to learn how Carmell Corp (Nasdaq: CTCX) is bringing the biggest technological revolution in regenerative skin and haircare to the…

Join Opthea Limited, a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, for a…

Join Tenax Therapeutics for LEVEL Setting, a panel of globally-recognized thought leaders in the field of heart failure, exploring the…

Join Annexon Biosciences for an overview of Guillain-Barré Syndrome (GBS), the most common cause of acute neuromuscular paralysis, featuring GBS…

Access the replay for more information.

With anticipation building for the first clinical readouts expected later in 2024, join Hummingbird Bioscience and Dartmouth's Geisel School of…

Join TScan Therapeutics for a virtual KOL event, featuring hematologist/oncologists Ran Reshef, MD, MSc (Columbia University Irving Comprehensive Cancer Center) and Monzr M. Al Malki,…

Neurelis will host a 90-minute virtual investor call to highlight updates on two of its product candidates. NRL-1004 for Acute…

Join Aligos Therapeutics for a virtual KOL event featuring Stephen Harrison, MD (Visiting Professor, Radcliffe Department of Medicine, University of…

Join FibroGen for Part I of a virtual KOL investor event series featuring Andrew Ko, MD (University of California San…

Dr. Anthony J. Olszanski, M.D., RPh (Fox Chase Cancer Center) will join Antengene for their 2023 R&D Day. During the event, Antengene’s…